Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer’s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation
Cathrine Petersen, Amber Nolan, Elisa de Paula França Resende, et al.
Acta Neuropathologica (2019) Vol. 138, Iss. 4, pp. 597-612
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Alzheimer disease
David S. Knopman, Hélène Amieva, Ronald C. Petersen, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 1476
New insights into atypical Alzheimer's disease in the era of biomarkers
Jonathan Graff‐Radford, Keir Yong, Liana G. Apostolova, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 3, pp. 222-234
Open Access | Times Cited: 408
Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia
Chao Wang, Monica Xiong, Maud Gratuze, et al.
Neuron (2021) Vol. 109, Iss. 10, pp. 1657-1674.e7
Open Access | Times Cited: 223
Tauopathies: new perspectives and challenges
Yi Zhang, Kaimin Wu, Yang Liu, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 181
Comorbid neuropathological diagnoses in early versus late-onset Alzheimer’s disease
Salvatore Spina, Renaud La Joie, Cathrine Petersen, et al.
Brain (2021) Vol. 144, Iss. 7, pp. 2186-2198
Open Access | Times Cited: 173
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Joseph Therriault, Tharick A. Pascoal, Firoza Z Lussier, et al.
Nature Aging (2022) Vol. 2, Iss. 6, pp. 526-535
Open Access | Times Cited: 166
APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review
Sheina Emrani, Hirra A. Arain, Cassandra DeMarshall, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 149
Is Alzheimer disease a disease?
Amos D. Korczyn, Lea T. Grinberg
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 245-251
Closed Access | Times Cited: 60
Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Joseph Therriault, Suzanne E. Schindler, Gemma Salvadó, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 232-244
Closed Access | Times Cited: 51
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 6
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268756-jnumed.124.268756
Closed Access | Times Cited: 2
Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET
Renaud La Joie, Adrienne Visani, Orit H. Lesman‐Segev, et al.
Neurology (2020) Vol. 96, Iss. 5
Open Access | Times Cited: 94
Recent update on the heterogeneity of the Alzheimer’s disease spectrum
K. A. Jellinger
Journal of Neural Transmission (2021) Vol. 129, Iss. 1, pp. 1-24
Closed Access | Times Cited: 85
A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh, et al.
Neurochemical Research (2022) Vol. 48, Iss. 3, pp. 745-766
Closed Access | Times Cited: 53
Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease
Jeremy A. Tanner, Leonardo Iaccarino, Lauren Edwards, et al.
Brain (2022) Vol. 145, Iss. 12, pp. 4489-4505
Open Access | Times Cited: 51
Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
Nawal Alsubaie, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1290-1290
Open Access | Times Cited: 50
Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease
Christina B. Young, Joseph R. Winer, Kyan Younes, et al.
JAMA Neurology (2022) Vol. 79, Iss. 6, pp. 592-592
Open Access | Times Cited: 48
Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain
Christina M. Moloney, Sydney A. Labuzan, Julia E. Crook, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 3, pp. 1029-1040
Open Access | Times Cited: 40
Does Alzheimer's disease with mesial temporal lobe epilepsy represent a distinct disease subtype?
Ifrah Zawar, Jaideep Kapur
Alzheimer s & Dementia (2023) Vol. 19, Iss. 6, pp. 2697-2706
Open Access | Times Cited: 27
Diagnosis and Management of Posterior Cortical Atrophy
Keir Yong, Jonathan Graff‐Radford, Samrah Ahmed, et al.
Current Treatment Options in Neurology (2023) Vol. 25, Iss. 2, pp. 23-43
Open Access | Times Cited: 24
Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History
Félix Bermejo‐Pareja, Teodoro del Ser
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 536-536
Open Access | Times Cited: 9
Pathobiological Subtypes of Alzheimer Disease
K. A. Jellinger
Dementia and Geriatric Cognitive Disorders (2020) Vol. 49, Iss. 4, pp. 321-333
Open Access | Times Cited: 54
Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer’s disease
Joseph Therriault, Tharick A. Pascoal, Mélissa Savard, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 659
Closed Access | Times Cited: 31
Alzheimer's disease phenotypes show different sleep architecture
Neus Falgàs, Christine M. Walsh, Leslie Yack, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 8, pp. 3272-3282
Open Access | Times Cited: 18
Neuropathological assessment of the Alzheimer spectrum
K. A. Jellinger
Journal of Neural Transmission (2020) Vol. 127, Iss. 9, pp. 1229-1256
Closed Access | Times Cited: 49
Page 1 - Next Page

Scroll to top